Browsing by Author Kantarjian, Hagop M.
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) |
|---|---|---|
| 11-Jun-2015 | A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis. | Vannucchi, Alessandro M.; Kantarjian, Hagop M.; Kiladjian, Jean-Jacques; Gotlib, Jason; Cervantes Requena, F.; Mesa, Ruben A.; Sarlis, Nicholas J.; Peng, Wei; Sandor, Victor; Gopalakrishna, Prashanth; Hmissi, Abdel; Stalbovskaya, Viktoriya; Gupta, Vikas; Harrison, Claire N.; Verstovsek, Srdan; García Pagán, Juan Carlos |
| Feb-2014 | Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies | Mesa, Ruben A.; Kiladjian, Jean-Jacques; Verstovsek, Srdan; Al-Ali, Haifa Kathrin; Gotlib, Jason; Gisslinger, Heinz; Levy, Richard; Siulnik, Andres; Gupta, Vikas; Khan, Mahmudul; DiPersio, John F.; McQuitty, Mari; Catalano, John V.; Hunter, Deborah S.; Knoops, Laurent; Deininger, Michael W.; Cervantes Requena, F.; Miller, Carole; Vannucchi, Alessandro M.; Silver, Richard T.; Barbui, Tiziano; Talpaz, Moshe; Barosi, Giovanni; Winton, Elliott F.; Mendeson, Estella; Harvey, Jimmie H.Jr.; Arcasoy, Murat O.; Hexner, Elizabeth; Lyons, Roger M.; Paquette, Ronald; Raza, Azra; Sun, William; Sandor, Victor; Kantarjian, Hagop M.; Harrison, Claire N. |
| 10-Jul-2016 | Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial | Cortes, Jorge E.; Saglio, Giuseppe; Kantarjian, Hagop M.; Baccarani, Michele; Mayer, Jiří; Boqué Genovard, Concepción; Shah, Neil P.; Chuah, Charles; Casanova, Luis; Bradley-Garelik, Brigid; Manos, George; Hochhaus, Andreas |
| 9-Mar-2017 | Long-term outcomes of imatinib treatment for chronic myeloid leukemia. | Hochhaus, Andreas; Larson, Richard A.; Guilhot, François; Radich, Jerald P.; Branford, Susan; Hughes, Timothy P.; Baccarani, Michele; Deininger, Michael W.; Cervantes Requena, F.; Fujihara, Satoko; Ortmann, Christine E.; Menssen, Hans D.; Kantarjian, Hagop M.; O'Brien, Stephen G.; Druker, Brian J. |
| 5-Feb-2014 | Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on frontline imatinib or nilotinib 300 mg twice daily. | Hughes, Timothy P.; Hochhaus, Andreas; Kantarjian, Hagop M.; Cervantes Requena, F.; Guilhot, François; Niederwieser, Dietger; le Coutre, Philipp D.; Rosti, Gianantonio; Ossenkoppele, Gert J.; Lobo, Clarisse; Shibayama, Hirohiko; Fan, Xiaolin; Menssen, Hans D.; Kemp, Charisse; Larson, Richard A.; Saglio, Giuseppe |